Add-on activity
This activity includes patient counseling videos.
Program Description
Respiratory syncytial virus (RSV) commonly presents as an upper respiratory infection that can cause increased morbidity and mortality for older patients, especially for those with underlying comorbidities. The current treatment paradigm for RSV is limited and mostly supportive care, but several RSV vaccine candidates are under development in various stages of clinical trials. Pharmacists are in a unique position to identify patients with risk factors for more severe disease and ensure patients are familiar with tactics to reduce transmission of RSV. Pharmacists can provide education on the effectiveness of emerging RSV vaccines in preventing disease complications. Expert panelists will outline the pharmacist’s role in promoting acceptance of new vaccines and overcoming barriers associated with reduced vaccination coverage among some populations by addressing disparities in care. Included in this activity are patient counseling videos to illustrate the role of the pharmacist in educating patients about RSV and emerging vaccines.
Target audience: Retail/community, long-term care, and health-system pharmacists
Type of activity: Application
Release date: August 10, 2022
Expiration date: August 10, 2023
Time to complete activity: 1.5 hours
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Determine the incidence, risk factors, and diagnostic criteria for respiratory syncytial virus (RSV) in older adults
- Examine the most current efficacy data for emerging RSV vaccines as well as administration, dosing, and potential adverse effects
- Identify the role of the pharmacist in educating patients about preventing RSV infections, including information about emerging vaccines for RSV
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
